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THE STRUGGLE FOR RURAL PHARMACIES:
WILL MEDICARE'S NEW PRIVATELY
INSURED PRESCRIPTION DRUG
CO VERA GE JEOPARDIZE VALUABLE
PHARMACY SER VICES FOR RURAL
SENIORS?
Courtney C. Crouch, III*
INTRODUCTION
A century ago, the concept of government-insured health care in this
country was merely an ambitious idea. That idea, inspired by newly
established programs in Europe,' eventually evolved into a national
movement to coordinate medical care for all Americans. It also
sparked a lively and continuing debate in our nation's politics about
the role of government in providing health care to its citizens. This
J.D. Candidate May 2005, The Catholic University of America, Columbus School
of Law, B.S. 1998 University of Arkansas. The author wishes to thank all those
who assisted him on this Comment, especially his family and friends for their
support, Rev. Raymond C. O'Brien for his edits, and the editorial board and staff
of the Journal for their input and hard work.
1. Historians often cite the 1883 inauguration of the German health insurance
program by Chancellor Otto von Bismark as the precursor of modern social
welfare programs. However, the principle of government involvement in health
care dates as far back as the ancient Greek civilizations where city-states were
known to have tax-subsidized public physicians. In fact, Bismark's program was
not the first such compulsory health plan in Europe. The state of Prussia enacted a
compulsory health insurance law some twenty-nine years earlier, in 1854. It was
the success of the German initiative, however, that inspired other European
countries, including Great Britain, to follow suit, providing a catalyst for eventual
comprehensive worker protections commonly known today as "social insurance."
PETER A. CORNING, THE EVOLUTION OF MEDICARE ... FROM IDEA TO LAW at
Introduction (1969), reprinted at http://www.ssa.gov/history/corning.html (last
visited Nov. 26, 2004).
2. Id. at Introduction. Discussions of a national health insurance system in
the United States first appeared in earnest in the early twentieth century.
Encouraged by the passage of the British National Health Insurance program in
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discourse regarding the merits of public versus private health insurance
is vividly illustrated by the debate surrounding the creation and
improvement of the Medicare program.
The national health insurance movement reached a major milestone
in 1965 with the historic signing of legislation creating Medicare and
Medicaid.3 In developing these landmark national programs to ensure
1911, a number of American political and intellectual leaders organized a
movement to enact health insurance and other social assistance measures on a
state-by-state basis. Over the next decade, a debate took shape over the
government's role in health care that characterized the attitudes and positions on
this issue that continue to this day. Id.
3. The Social Security Amendments of 1965, Pub. L. No. 89-97, 79 Stat. 286
(1965). The Social Security Amendments of 1965 created both Medicare and
Medicaid as they are known today. CTRS. FOR MEDICARE & MEDICAID SERVS.,
MEDICARE INFORMATION RESOURCE, at http://cms.hhs.gov/medicare (last visited
Nov. 26, 2004). As established by the Act, Medicare was designed as a two-part
insurance program to provide coverage for medical expenses of the elderly. Part
A, the "basic" program, was to cover inpatient hospital and related expenses,
including ninety days of hospital care, one hundred days of nursing home care, one
hundred at-home care visits for each illness, and outpatient hospital services.
These benefits were financed through social security taxes and subject to
"deductibles," "coinsurance," and other conditions. Part B was a voluntary
program to provide "supplementary" coverage for physician and outpatient
services, additional home health services, diagnostic and laboratory work, certain
therapy services, ambulance services, and certain other expenses. Medicare would
cover eighty percent of Part B expenses above a deductible amount, which was to
be financed through a monthly premium charged to each beneficiary, with a
matching amount paid by the federal government through general revenues.
CORNING, supra note 1, at Ch. 4 n. 39.
In 1972, Congress amended the program to add coverage for disabled
adults under age sixty-five and those suffering from permanent kidney failure that
requires dialysis or a transplant, known as end-stage renal disease (ERSD). CTRS.
FOR MEDICARE & MEDICAID SERVS., CMS/HCFA HISTORY [hereinafter
CMS/HCFA HISTORY], at http://cms.hhs.gov/about/history/ (last visited Nov. 28,
2004). See also CTRS. FOR MEDICARE & MEDICAID SERVS., MEDICARE
INFORMATION RESOURCE, at http://cms.hhs.gov/medicare/ (last visited Nov. 28,
2004). Today, Medicare covers approximately forty million Americans including
those age sixty-five or over, those on disability, and those with permanent kidney
failure. CTRS. FOR MEDICARE & MEDICAID SERVS., MEDICARE INFORMATION
RESOURCE, at http://cms.hhs.gov/medicare/ (last visited Nov. 28, 2004). Medicare
continues to cover "inpatient hospital services, skilled nursing facility (SNF)
benefits, and hospice care" (under Part A), as well as "physician and outpatient
hospital services, annual mammography and other cancer screenings, and services
such as laboratory procedures and medical equipment" (under Part B) and certain
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access to quality health care for our nation's most needy citizens, the
elderly and the poor, those favoring publicly insured health care
prevailed. Supporters of government insurance successfully argued
home nursing visits (under Parts A and B). THE HENRY J. KAISER FAMILY
FOUND., MEDICARE QUICK FACTS, at http://www.kff.org/medicare/quickfacts.cfm
(last visited Nov. 28, 2004).
In addition to the creation of Medicare, the 1965 act also greatly expanded
the previous Kerr-Mills program, today known as Medicaid, by extending "medical
indigency" benefits to eligible individuals under age sixty-five. CORNING, supra
note 1, at Ch. 4 n. 39. The Medicaid program today provides the greatest source of
funding for medical insurance for the nation's poorest individuals and families.
CTRS. FOR MEDICARE & MEDICAID SERVS., MEDICAID: A BRIEF SUMMARY
[hereinafter MEDICAID: A BRIEF SUMMARY], at
http://cms.hhs.gov/publications/overview-medicare-medicaid/default4.asp (last
visited Nov. 28, 2004). The program is administered by the states, and the
requirements for eligibility and guidelines for services are established by each
state. However, the federal government requires that federal Medicaid funds only
be extended to persons who fall within the following classes: children, pregnant
women, adults in families with dependent children, individuals with disabilities,
and individuals age sixty-five and above. CTRS. FOR MEDICARE & MEDICAID
SERVS., WELCOME TO MEDICAID: SITE FOR CONSUMER INFORMATION, at
http://cms.hhs.gov/medicaid/consumer.asp (last visited Nov. 28, 2004). Only those
poor persons whose income and assets fall below specified levels (determined by
each state within federal guidelines) may become eligible to receive Medicaid.
Generally, persons who qualify fall near or below the federal poverty level.
MEDICAID: A BRIEF SUMMARY, supra.
In order to receive federal matching funds, a state's Medicaid program
must also meet mandatory requirements for basic medical services. Among these
services are nursing home services, which are not covered under Medicare. Id.
The federal government may also provide states with matching funds for certain
other optional services. One such service that most state Medicaid programs cover
is prescription drugs. Id. Finally, many states also provide "State-only" programs
to provide medical coverage for certain low-income individuals who do not qualify
for Medicaid. Id.
Currently, over six million Medicare beneficiaries also receive assistance
from Medicaid. For these individuals, known as "dual enrollees," Medicaid pays
for their Medicare premiums as well as services not covered under Medicare, such
as prescription drugs and long-term care. Expenses for dual enrollees account for
thirty-five percent of total Medicaid spending, with an average of $12,318 per
elderly enrollee and $11,776 per disabled enrollee, as opposed to $2,334 per
regular adult enrollee under age sixty-five. In addition, eighty percent of all
Medicaid spending for prescription drugs goes to the elderly and the disabled.
KAISER COMM'N ON MEDICAID AND THE UNINSURED, THE MEDICAID PROGRAM
AT A GLANCE, at http://www.kff.org/medicaid/200403-index.cfm (last visited Nov.
28, 2004).
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that the private sector could not guarantee the quality of care that
seniors deserved .
The public versus private debate has continued, particularly with
respect to coverage for prescription drugs. The increase of medical
treatments involving prescription medications coupled with the
dramatic rise in prescription drug prices have caused continued
disagreement over how to address outpatient medicines within
Medicare. As Congress finally, but narrowly, reached agreement to
enact the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003,- proponents of a privately insured
approach prevailed. This approach, however, has created concerns
about whether it will truly provide adequate coverage, especially for
seniors in rural America.' One concern is the potential impact of the
privately insured Medicare prescription drug benefit on rural
community pharmacies.
More prevalent than primary care physicians in rural America,' local
pharmacists are on the front line of health care in these communities.
However, many independent pharmacies like those typically found in
rural areas are struggling as a result of increased third-party
discounting, primarily by pharmacy benefit management companies
(PBMs), 9 as well as competition from mail order, chains, and mass
4. See CORNING, supra note 1, at Ch. 4.
5. The Medicare Prescription Drug, Improvement, and Modernization Act of
2003, Pub. L. No. 108-173, 117 Stat. 2066 (2003).
6. Among these concerns are availability of coverage plans, complexity of the
benefit, purchasing power of the risk pool, and access to pharmacy services. See
generally MAINE RURAL HEALTH RESEARCH CTR. & RURAL POLICY RESEARCH
INST. RURAL HEALTH PANEL, DESIGNING A PRESCRIPTION DRUG BENEFIT FOR
RURAL MEDICARE BENEFICIARIES (Aug. 31, 2000) [hereinafter MAINE], available
at http://www. rupri.org/ruralHealth/publications/default.asp?flashVersion=6&
SubSection=policyPapers&Panel=l (last visited Nov. 28, 2004).
7. Deborah Epstein, Can Rural Pharmacy Survive, DRUG TOPICS,
at http://www.drugtopics.com (July 22, 1996).
8. Thomas D. Rowley, Pharmaceutical Consequences, Rural Policy Research
Institute, at www.rupri.org/editorial/Default.asp?edlD=49&ACTION=
READ (Aug. 28,2002).
9. CONG. RESEARCH SERV., THE COST OF PRESCRIPTION DRUGS FOR THE
UNINSURED ELDERLY AND LEGISLATIVE APPROACHES 4 (2001). PBMs are private
entities that administer prescription drug insurance benefits for health plans,
HMOs, employers, unions, and other groups. In administering drug benefits,
PBMs "construct a complex web of relationships with retail pharmacies, drug
manufacturers, doctors, and patients to manage drug utilization and costs for their
clients." ANNA COOK ET AL., THE HENRY J. KAISER FAMILY FOUND., THE ROLE
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merchandisers.' ° Meanwhile, the profession itself is struggling to
attract young new pharmacists to rural areas as the older pharmacists
retire." Because the private entities that will administer the new
Medicare prescription drug benefit will likely extract further discounts
from these pharmacists, the future of rural family pharmacies is
uncertain. If these rural pharmacies cannot survive, this loss could
bring significant costs to rural beneficiaries, their communities, and our
health care system as a whole.
This Comment examines the potential impact of the privately
insured Medicare prescription drug benefit outlined in the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003 on
the rural pharmacy profession. The Comment first summarizes past
legislative efforts to include prescription drug coverage under
Medicare. Next, the Comment outlines the prescription drug benefit
program and the interim prescription drug discount card program set
forth in the Act. The Comment then analyzes the effect of these
provisions on rural community pharmacies and comments on the
potential costs to seniors, their communities, and the health care
system as a whole from the loss of rural pharmacies. Finally, this
Comment looks at possible legislative solutions to ensure that seniors
in rural areas do not lose the valuable services provided by rural
pharmacies.
2
OF PBMs IN MANAGING DRUG COSTS: IMPLICATIONS FOR A MEDICARE DRUG
BENEFIT at Executive Summary (2000), available at http://www.kff.org/
medicare/1543-index.cfm (last visited Nov. 28, 2004). PBMs typically negotiate
with drug manufacturers to obtain rebates, as well as contract for price concessions
from pharmacies in order to reduce pharmaceutical costs. See id. See also further
discussion of the role of PBMs infra parts III.A. and B. Additional third-party
purchasers of prescription medicines include insurance companies, HMOs, and
other government program administrators.
10. Epstein, supra note 7, at 1. See also Thomas D. Rowley, Future Uncertain
for Rural Pharmacies, 9 RURAL HEALTH NEWS 1, 3 (2002), available at
http://www.nal.usda.gov/ric/richs/rhnlinks.htm (last visited Nov. 28, 2004).
11. NAT'L RURAL HEALTH ASS'N, PROTECTING RURAL BENEFICIARIES WITH A
MEDICARE PRESCRIPTION DRUG BENEFIT 3 (2003), available at
http://www.nrharural.org /pdf/pharm.pdf (last visited Nov. 28, 2004).
12. This Comment does not discuss Medicare reform provisions relating to
traditional Medicare parts A and B that are separate from the prescription drug
benefit, including those relating to rural hospitals.
2004]
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I. MODERNIZING MEDICARE TO INCLUDE PRESCRIPTION MEDICINES
A. Congress Attempts to Create a Medicare Drug Benefit
Policymakers have debated the need to add prescription drug
coverage to Medicare since the program's original enactment. 3 The
costs of such coverage, along with disagreements over the role of the
private sector in administering the coverage, have been the two central
issues surrounding the debate and have provided the biggest obstacles
to its resolution. 14 The 1967 amendments to the Social Security Act
called for the creation of the Task Force on Prescription Drugs to
study the possibility of adding a prescription drug benefit to the newly
created Medicare program. 5 However, not until two decades later did
Congress make the first of three major attempts to pass legislation
providing a prescription drug benefit under Medicare.1
6
In 1988, Congress passed the Medicare Catastrophic Coverage Act
(MCCA), 7 which would have phased in "catastrophic" prescription
drug coverage beginning in 1991.18 This coverage, however, never
materialized. Due to a number of reasons, including a major increase
in cost estimates and opposition to a supplemental premium charge to
higher income beneficiaries, the MCCA was repealed before it began.'9
The second major attempt came as part of the Clinton
administration's comprehensive health care reform package in 1993.20
13. JENNIFER O'SULLIVAN, CONG. RESEARCH SERV., MEDICARE
PRESCRIPTION DRUG COVERAGE FOR BENEFICIARIES: BACKGROUND AND ISSUES 1
(2003).
14. Id. at 25.
15. CTRS. FOR MEDICARE AND MEDICAID SERVS., HISTORY OF MEDICARE AND
MEDICAID, at http://cms.hhs.gov/about/history/ssachr.asp (last visited Nov. 28,
2004).
16. O'SULLIVAN, supra note 13, at 25.
17. Medicare Catastrophic Coverage Act, 102 Stat. 683 (1988) (repealed 1989).
18. O'SULLIVAN, supra note 13, at 25. "Catastrophic" coverage is where the
provider will typically cover the full costs of medicines once the beneficiary
reaches a specified amount in out-of-pocket drug expenses, often referred to as the
catastrophic limit or out-of-pocket limit. The benefit under the MCCA was to
cover all outpatient medicine expenses above a deductible amount of $600 (in the
first year), subject to a 50% coinsurance cost. The deductible for future years was
indexed so that 16.8% of Medicare beneficiaries would have prescription drug
costs that met the deductible each year. The coinsurance was also scheduled to be
progressively lowered to 20% by 1993. Id.
19. Id.
20. Id. at 26.
Struggle for Rural Pharmacies
Introduced in Congress as the Health Security Act,2" President
Clinton's plan called for the addition of a prescription drug benefit to
12Medicare. Like traditional Medicare, the benefit was to be financed
primarily through general federal revenues with some costs covered
• 23
through beneficiary premiums. However, after months of extensive
hearings and negotiations on Capitol Hill, the comprehensive package
ultimately fell victim to vast disagreements over the government's role
in health care and failed to muster enough support to make it to the
floor of either chamber.
The most recent effort to include prescription coverage within
Medicare began as a result of the National Bipartisan Commission on
the Future of Medicare established by the Balanced Budget Act of
1997.2 Although the Commission was unsuccessful in agreeing on a
Medicare reform proposal, it managed to renew policymakers' interest
in addressing the program's lack of comprehensive prescription drug
26
coverage.
Several measures were introduced in the 106th Congress to establish
a prescription drug benefit under Medicare.27 Consistent with previous
debates, these proposals reflected contrasting views over whether the
government or the private sector should assume a greater portion of
the financial risk of administering the program and whether a benefit
should be available to all beneficiaries or offered principally to those in
lower income brackets. In 1999, the Clinton administration put forth
its new plan, which proposed a voluntary drug benefit available to all
21. H.R. 3600, 103d Cong. (1993); S. 1757, 103d Cong. (1993).
22. O'SULLIVAN, supra note 13, at 26. The President's plan would have
included a $250 deductible and a 20% coinsurance cost, with Medicare picking up
the remaining 80% of beneficiaries' medicine costs above the deductible amount.
Id. The proposed benefit also included an out-of-pocket limit of $1,000 and would
have helped nearly six of every ten Medicare beneficiaries. Id.
23. Id.
24. See Dana Priest, Democrats Pull the Plug on Health Care Reform, WASH.
POST, Sept. 27, 1994, at Al; Dana Priest, Where Health Care Reform Effort Failed;
Some Officials Blame White House as Plan Appears Dead for Year, WASH. POST,
Aug. 27, 1994, at Al.
25. O'SULLIVAN, supra note 13, at 26. Balanced Budget Act of 1997, Pub. L.
No. 105-33, § 4021, 111 Stat. 251, 347-350 (1997).
26. O'SULLIVAN, supra note 13, at 26-27.
27. Id. at 27.
28. Id. at 26.
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Medicare beneficiaries." However, the plan never gained approval
from Congress. Instead, in June 2000, the House of Representatives
narrowly passed a Republican-sponsored measure, the Medicare Rx
2000 Act,30 which would have created a Medicare prescription drug
benefit relying mostly on private insurance companies to provide
coverage." Despite approval of this measure in the House, though,
prescription drug benefit legislation stalled in the Senate.32
Many similar proposals were reintroduced during the 107th
Congress.33  As with previous proposals, those sponsored by
Republican members tended to rely on private entities to bear the
financial risk of providing the Medicare prescription drug benefit. The
Democratic alternatives tended to favor approaches similar to
traditional Medicare in which the federal government assumes most of
the coverage risk.34 In June 2002, the House approved a modified
version of the bill it passed during the 106th Congress, entitled the
Medicare Modernization and Prescription Drug Act of 2002."5 The
following month, the Senate passed the Greater Access to Affordable
Pharmaceuticals Act,36 which related to the availability of generic
29. Id. at 27. This plan included 50% coverage for a beneficiary's prescription
drug costs up to a specified limit ($1,000 in 2002, increasing to $2,500 by 2008),
with full catastrophic coverage beginning when the beneficiary reached $4,000 in
out-of-pocket costs. The plan carried no deductible and proposed a monthly
premium of $25. Id.
30. Id. at 27. H.R. 4680, 106th Cong. (2000).
31. O'SULLIVAN, supra note 13, at 27. Under the bill, the federal government
would partially subsidize these private entities for the risk of insuring Medicare
beneficiaries' prescription drug costs. Id. Benefit plans had to provide "qualified"
or "standard" coverage to be eligible. Id. "Standard" coverage consisted of a $250
deductible (in 2003); 50% cost-sharing for next $2,100 in prescription drug
expenses (in 2003); and an out-of-pocket limit at $6,000. Id.
32. Id. A number of Medicare prescription drug benefit plans were
introduced in the Senate during the 106th Congress, though none successfully
gained Senate approval. See, e.g., Medicare Expansion for Needed Drugs
(MEND) Act of 2000, S. 2753, 106th Cong. (2000); Medicare Modernization Act of
2000, S. 2342, 106th Cong. (2000); Medicare Outpatient Drug Act of 2000, S. 2758,
106th Cong. (2000); The Medicare Prescription Drug and Modernization Act of
2000, S. 2807, 106th Cong. (2000); Medicare Rx Drug Discount and Security Act of
2000, S. 2836, 106th Cong. (2000). See also MAINE, supra note 6.
33. See O'SULLIVAN, supra note 13, at 28.
34. John K. Iglehart, Health Policy 2001: Medicare and Prescription Drugs, 344
NEw ENG. J. MED. 1010, 1013 (Mar. 29, 2001).
35. H.R. 4954, 107th Cong. (2002). See also O'SULLIVAN, supra note 13, at 28.
36. S. 812, 107th Cong. (2002).
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drugs. Although this measure became a vehicle for Senate
consideration of a number of Medicare prescription drug benefit
proposals, none of them managed to capture the votes necessary to be
included within the generic drug bill.37
B. Controversial Medicare-Endorsed Prescription Drug Discount Card
Program Proposed
While the 107th Congress was debating how to address the need for
prescription drug coverage for our nation's seniors, President Bush
made an attempt to reduce the cost of prescription medicines for the
elderly. On July 12, 2001, the Bush administration unveiled a
Medicare prescription drug discount card program aimed at lowering
out-of-pocket medicine costs." The initiative was designed to be a
temporary measure, employing the concept of private discount drug
card programs already in existence, to be used until Congress enacted
a more comprehensive Medicare prescription drug benefit.3 9 Under
the program, Medicare would "endorse and promote a number of
privately-administered prescription drug discount card plans which
have a one-time maximum enrollment rate of twenty-five dollars per
plan., 40 Although none of the many card programs then available
through private entities or states would have met the administration's
specifications, it was expected that a number of the larger programs
would attempt to qualify.41
The prescription drug discount card initiative was met with
42ambivalence from seniors' groups and resistance from pharmacy
37. O'SULLIVAN, supra note 13, at 28.
38. THE HENRY J. KAISER FAMILY FOUND., PRESCRIPTION DRUG DISCOUNT
CARDS: CURRENT PROGRAMS AND ISSUES 1 (2002), available at
http://www.kff.org/medicare /6014-index.cfm (last visited Nov. 28, 2004). See also
M. ANGELES VILLARREAL, CONG. RESEARCH SERV., PRESIDENT BUSH'S
PROPOSED MEDICARE-ENDORSED DRUG DISCOUNT CARD INITIATIVE: STATUS
AND ISSUES at Summary (2003).
39. VILLARREAL, supra note 38, at Summary. See also THE HENRY J. KAISER
FAMILY FOUND., supra note 38, at 7.
40. VILLARREAL, supra note 38, at Summary.
41. THE HENRY J. KAISER FAMILY FOUND., supra note 38, at v. See further
explanation of how prescription drug discount cards work infra part III. A.
42. See, e.g., Statement by AARP CEO Bill Novelli on Medicare Prescription
Discount Card Proposed Regulation (Mar. 1, 2002), available at
http://www.aarp.org/researchl/press/presscurrentnews/cn-2002/ (last visited Nov. 28,
2004); Press Release, Nat'l Comm. to Preserve Social Security and Medicare,
20041
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organizations and Democratic members of Congress. 3 The opposition
centered on concerns that (1) prescription drug discount cards did not
provide significant savings to seniors, (2) the proposed program would
not improve upon the discount cards already widely available to
seniors, (3) it would provide a "boon" to already highly profitable
PBMs and drug manufacturers, and (4) such a program might delay
action on a more meaningful Medicare prescription drug benefit.4
In July 2001, two pharmacy groups filed suit in federal district court
against the Centers for Medicare and Medicaid Services (CMS)
45
seeking to enjoin the discount card program." The lawsuit alleged that
the administration lacked statutory authority to implement the
program and had violated proper procedure in establishing it.47 After
Discount Drug Card Doesn't Respond to Seniors Lack of Rx Coverage (Mar. 4,
2002).
43. See, e.g., Press Release, Pharmacy Benefits All Coalition, Rx Discount
Card Plan Called Ill-conceived, Unworkable and Bad for Seniors, Failing to
Address Real Problem (July 12, 2001), available at http://www.nacds.org/
wmspage.cfm?parml=1467 (last visited Nov. 28, 2004); Press Release, Senate
Democratic Policy Comm., The Bush Administration's Discount Plan: A Boon to
Big Business at the Expense of Seniors and Their Local Pharmacies (Aug. 2, 2001).
44. See, e.g. Press Release, Nat'l Comm. to Preserve Social Security and
Medicare, supra note 42; Press Release, Pharmacy Benefits All Coalition, supra
note 43; Press Release, Senate Democratic Policy Committee, supra note 43.
45. The Centers for Medicare and Medicaid Services, formerly the Health
Care Financing Administration (HCFA), is the federal agency charged with
administering Medicare and Medicaid. HCFA was created in 1977 to coordinate
the two programs, which originally came under the responsibilities of the Social
Security Administration (SSA) and the Social and Rehabilitation Service (SRS),
respectively. CMS/HCFA HISTORY, supra note 3.
46. Complaint, Nat'l Ass'n of Chain Drug Stores v. Thompson, 241 F. Supp. 2d
29 (D.D.C. 2003) (No. 01-1554). See also Press Release, Nat'l Ass'n of Chain Drug
Stores, Community Pharmacy Files Suit Against Federal Government, at
http://www. nacds.org/wmspage.cfm? parml=1468 (July 18, 2001).
47. The plaintiffs, the National Association of Chain Drug Stores (NACDS)
and the National Community Pharmacists Association (NCPA), specifically
alleged that the Department of Health and Human Services (HHS) and CMS:
(1) established the program without legal authority; (2)
violated the notice and comment requirements of the
Administrative Procedures Act in establishing the program; (3)
adopted regulatory standards that were arbitrary, capricious, and
an abuse of discretion; (4) failed to comply with the
requirements of the Federal Advisory Committee Act; and (5)
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issuing a preliminary injunction, the district court stayed the
proceedings in November 2001 to allow for public comment on the
proposal.48 The administration subsequently modified its proposal and
formally issued a new rule,' 9 but five months later the court
permanently enjoined the program's establishment and held that the
administration lacked statutory authority to proceed.0  Although
legislation was introduced shortly thereafter that would have
authorized the Secretary of Health and Human Services (HHS) to
implement a discount card program,5 the administration did not
further pursue the program.
C. Medicare 'Part D' Prescription Drug Benefit Becomes Law
Although previous attempts had come up short, the 108th Congress
managed to enact a Medicare prescription drug benefit. On June 27,
2003, the Senate passed the Prescription Drug and Medicare
Improvement Act of 2003 (S. 1)52 by a count of 76-21.5' The House, a
few hours later and by a slim one-vote margin, approved the Medicare
Prescription Drug and Modernization Act of 2003 (H.R. 1).54 Both
versions established a Medicare prescription drug benefit, set to begin
January 1, 2006, within a new Medicare Part D. Both bills also relied
on private insurance carriers to provide the coverage while assuming a
significant portion of the financial risk.55 Participating plans would
had unlawfully delegated regulatory authority under the care
program to a group of private, self-interested card issuers.
THE HENRY J. KAISER FAMILY FOUND., supra note 38, at n.14 (citing Complaint at
4, Nat'l Ass'n of Chain Drug Stores (No. 01-1554)).
48. Nat'l Ass'n of Chain Drug Stores v. Thompson, 2001 U.S. Dist. LEXIS
14417 (D.D.C. 2001) (order granting preliminary injunction). The judge later
ruled that the suit could proceed once the final proposed rule was published. THE
HENRY J. KAISER FAMILY FOUND, supra note 38, at n.14.
49. VILLARREAL, supra note 38, at Summary.
50. Nat'l Ass'n of Chain Drug Stores v. Thompson, 241 F. Supp. 2d 29 (D.D.C.
2003).
51. VILLARREAL, supra note 38, at Summary.
52. S. 1, 108th Cong. (2003).
53. JENNIFER O'SULLIVAN, CONG. RESEARCH SERV., MEDICARE PRESCRIPTION
DRUG PROVISIONS OF S. 1, AS PASSED BY THE SENATE, AND H.R. 1, AS PASSED BY
THE HOUSE at Summary (2003).
54. H.R. 1, 108th Cong. (2003) (enacted). The vote was 216-215, with one
member voting present. O'SULLIVAN, supra note 53, at Summary.
55. O'SULLIVAN, supra note 53, at Summary.
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have to offer "standard coverage" or its actuarial equivalent.56 Both
measures provided greater assistance to lower-income seniors and
offered additional federal subsidies where necessary to ensure plan
participation in all areas. Finally, both bills authorized the
establishment of a temporary Medicare-endorsed prescription drug
discount program (essentially equivalent to President Bush's previous
proposal) until the Part D program would be fully implemented.57
After a conference committee was named, several months of
negotiations followed to resolve a number of differences between
provisions of S. 1 and H.R. 1.18 The conferees filed their report on
November 21, 2003, outlining the final measure, the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003.' 9
The House narrowly approved the bill in a controversially
administered vote just before sunrise the next morning.60 Three days
later the measure cleared the Senate with comparative ease (by a vote
of 55-45),6l though a few senators protested the unprecedented
61procedural nature of the House vote. On December 8, 2003,
President Bush signed the bill into law, creating the largest expansion
of the Medicare program since its creation. 63
56. Actuarial equivalent as used here refers to a plan having the same dollar
value as the standard coverage.
57. O'SULLIVAN, supra note 53, at Summary.
58. See id.
59. H.R. CoNF. REP. No. 108-391 (2003), reprinted in 2003 U.S.C.C.A.N. 2066.
60. See Robert Pear & Robin Toner, Sharply Split, House Passes Broad
Medicare Overhaul, N.Y. TIMES, Nov. 23, 2003, at Al. The fifteen-minute roll call
vote on final passage of the 1100-page conference report began at 2:58 a.m.
following only a few short hours of debate. Though the legislation appeared to be
headed for a narrow defeat (216-218) at the end of the fifteen-minute roll call,
Republican House leaders held the roll call open for nearly three hours until, with
the help of Bush administration officials, they succeeded in strong-arming several
members opposed to the measure to change their votes. Id. The final vote was
220-215. H.R. 1, 108th Cong. (2003) (enacted).
61. H.R. 1, 108th Cong. (2003) (enacted).
62. Pear & Toner, supra note 60, at Al.
63. See Statement by the Press Secretary on H.R. 1, The White House (Dec. 8,
2003), available at http://www.whitehouse.gov/news/releases/2003/12/20031208-
6.html (last visited Nov. 28, 2004); Fact Sheet: Medicare Prescription Drug,
Improvement and Modernization Act of 2003, The White House (Dec. 8, 2003),
available at http://www.whitehouse.gov/news/releases/2003/12/20031208-3.
html (last visited Nov. 28, 2004).
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D. The Medicare Prescription Drug, Improvement, and Modernization
Act: A Privatized Approach
Consistent with its two component bills, the Medicare Prescription
Drug, Improvement, and Modernization Act of 20036 establishes, as of
January 1, 2006, a new Medicare prescription drug benefit provided by
65private insurance carriers. Under the Act, "standard coverage" for
the year 2006 is outlined as a $250 deductible, twenty-five percent
beneficiary cost sharing for prescription drug expenses between $251
and $2,250, and no coverage beyond the $2,250 initial coverage limit
until the beneficiary reaches out-of-pocket costs of $3,600 ($5,100 in
total prescription costs). 66 Once the beneficiary reaches the out-of-
pocket limit, the beneficiary will be responsible for five percent cost
sharing thereafter.67 The law does not specify a monthly premium
amount that beneficiaries will be required to pay, thus allowing
individual private carriers the discretion to determine premium
amounts for their plans. However, the Congressional Budget Office
(CBO) estimates the average monthly premiums will be thirty-five
dollars in 2006, rising to fifty-eight dollars in 2013.68 Beneficiaries will
be given the opportunity to enroll through Medicare during a
designated time period; those enrolling after the specified initial period
could be subject to higher premiums.69 Seniors with incomes from 100-
150 percent of the federal poverty level70 will be provided with
additional subsidies that will pay for most of the beneficiaries'
64. Medicare Prescription Drug, Improvement, and Modernization Act of
2003, Pub. L. No. 108-173, 117 Stat. 2066 (2003).
65. THE HENRY J. KAISER FAMILY FOUND., PRESCRIPTION DRUG COVERAGE
FOR MEDICARE BENEFICIARIES: A SUMMARY OF THE MEDICARE PRESCRIPTION
DRUG, IMPROVEMENT, AND MODERNIZATION ACT OF 2003 2 (2003), available at
http://www.kff.org/medicare/6112.cfm (last visited Nov. 28, 2004).
66. Id. See also H.R. CONF. REP. No. 108-391, at 13-14, reprinted in 2003
U.S.C.C.A.N. 2066, 2076-2078.
67. H.R. CONF. REP. No. 108-391, at 14, reprinted in 2003 U.S.C.C.A.N. at
2077.
68. THE HENRY J. KAISER FAMILY FOUND., supra note 65, at 2.
69. O'SULLIVAN, supra note 53, at 4, 5. See also H.R. CONF. REP. No. 108-391,
at 9-11, 39, 41, reprinted in 2003 U.S.C.C.A.N. at 2073-2075, 2102, 2104.
70. According to the U.S. Department of Health and Human Services, the
federal poverty level in 2004 stands at $9,310 for an individual and $12,490 for
couples. U.S. DEP'T OF HEALTH AND HUMAN SERVS., PRIOR
HHS POVERTY GUIDELINES AND FEDERAL REGISTER REFERENCES (2004) (citing
69 Fed. Reg. 7336 (Feb. 13, 2004), available at http://aspe.hhs.gov/ poverty
/figures- fed-reg.shtml (last visited Nov. 28,2004).
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premium and cost-sharing expenses." Those who also qualify for
Medicaid benefits ("dual eligibles") will get their prescription
medications through Medicare rather than Medicaid.72
Other provisions allow for medication therapy management73 and
subsidies to encourage employers to maintain their retiree health
coverage.74 The required medication therapy management programs
must be developed with licensed pharmacists and physicians to target
beneficiaries who have multiple chronic conditions, use multiple
71covered medications, and are likely to have excessive drug expenses.
Employers who maintain retiree health plans that offer actuarially
71. See U.S. HOUSE OF REPRESENTATIVES COMM. ON WAYS AND MEANS,
SUMMARY OF MEDICARE CONFERENCE AGREEMENT 2 (2003), available at
http://waysandmeans. house.gov/media/pdf/healthdocs/confagreement.pdf (last
visited Nov. 28, 2004); H.R. CONF. REP. No. 108-391, at 44-51, reprinted in 2003
U.S.C.C.A.N. at 2107-2113.
72. DIANE ROWLAND, KAISER COMM. ON MEDICAID AND THE UNINSURED,
MEDICARE PRESCRIPTION DRUGS AND LOW-INCOME BENEFICIARIES at Figure 2
(2003), available at http://www.kff.org/medicaid/kcmul21503pres.cfm (last visited
Nov. 28, 2004). Dual eligibles with incomes below 100% of the federal poverty
level will have no premium costs and no initial coverage limit. They will pay
copays of $3 for brand name drugs and $1 for generics up to the catastrophic limit
($5100 in total drug spending) and no copays thereafter. Id. at Figure 5. See also
H.R. CONF. REP. No. 108-391, at 44-45, reprinted in 2003 U.S.C.C.A.N. at 2107-
2108. Beneficiaries whose incomes fall below 135% of poverty and who also meet
an assets test ($6,000 per individual/$9,000 per couple) will pay $5 for brand name
drugs and $2 for generics, with no deductible, no premium costs, and no cost-
sharing beyond the catastrophic limit. ROWLAND, supra, at Figure 6. See also
H.R. CONF. REP. No. 108-391, at 44-45, reprinted in 2003 U.S.C.C.A.N. at 2107-
2108. Those beneficiaries who have incomes between 135-150% of the federal
poverty level and meet an assets test ($10,000 per individual/$20,000 per couple)
will be required to pay a $50 deductible, a sliding scale premium, and a 15%
coinsurance up to the catastrophic limit, with copayments of $5 and $2 thereafter.
ROWLAND, supra, at Figure 6. See also H.R. CONF. REP. No. 108-391, at 45-46,
reprinted in 2003 U.S.C.C.A.N. at 2108-2109. Finally, all beneficiaries with
incomes below 135% of poverty and not enrolled in Medicaid will be eligible for
reduced copays and $600 in transitional assistance in each of 2004 and 2005 for
medicine purchases using their Medicare-endorsed prescription drug discount
card. U.S. HOUSE OF REPRESENTATIVES COMM. ON WAYS AND MEANS, supra note
71, at 1. See also H.R. CONF. REP. No. 108-391, at 70-71, 78-79, reprinted in 2003
U.S.C.C.A.N. at 2133, 2140-2141.
73. H.R. CONF. REP. No. 108-391, at 22-23, reprinted in 2003 U.S.C.C.A.N. at
2086-2087.
74. Id. at 62-63, reprinted in 2003 U.S.C.C.A.N. at 2125.
75. Id. at 23, reprinted in 2003 U.S.C.C.A.N. at 2086.
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equivalent prescription drug coverage will receive a twenty-eight
percent subsidy for drug expenses between $250 and $5,000.76
Also included is "fallback" insurance for areas where less than two
private carriers bid to offer Medicare prescription drug coverage."
Under the provision, the Secretary of HHS must contract with one
carrier in each of these areas to provide coverage. 8 These entities will
be required to provide the standard benefit79 and have their premiums
set by Medicare.8 0 The Act, however, does not allow for a national
81fallback plan.
One of the most controversial provisions of the legislation prohibits
the government from negotiating with drug manufacturers for
discounts.8' This provision was included in order to "promote
competition" among providers."' However, many members of
Congress and the public have argued that the source of the high
prescription prices is the drug manufacturing industry and that,
therefore, the Medicare program should use the collective purchasing
power of its forty million beneficiaries to obtain lower prices from
manufacturers. 84  A report issued by the Office of the Inspector
General for HHS in January 2001 found that the Department of
Veterans' Affairs was able to negotiate fifty-two percent lower prices
for medicines for its prescription drug coverage plan by purchasing
directly from the manufacturers. 85 At the same time, HMOs and other
76. Id. at 63, reprinted in 2003 U.S.C.C.A.N. at 2126.
77. Id. at 18, 33-34, reprinted in 2003 U.S.C.C.A.N. at 2081-2082, 2096-2097.
See also O'SULLIVAN, supra note 53, at 13.
78. H.R. CONF. REP. No. 108-391, at 33, reprinted in 2003 U.S.C.C.A.N. at
2096.
79. See description of "standard coverage," supra part I.D.
80. H.R. CONF. REP. No. 108-391, at 34-35, reprinted in 2003 U.S.C.C.A.N. at
2097-2098.
81. Id. at 33, reprinted in 2003 U.S.C.C.A.N. at 2096-2097.
82. Id. at 35, reprinted in 2003 U.S.C.C.A.N. at 2098.
83. Id.
84. Karin Fischer, Drug Measure Targeted: Democrats Want Agency to Be Able
to Get Lower Prices, CHARLESTON DAILY MAIL, Dec. 29, 2003, at ID.
85. OFFICE OF INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUMAN SERVS.,
OEI-03-00-00310, MEDICARE REIMBURSEMENT OF PRESCRIPTION DRUGS (2001),
available at http://www.oig.hhs.gov/oei/reports/oei-03-00-00310.pdf (last visited
Nov. 28, 2004).
2004]
114 Journal of Contemporary Health Law and Policy [Vol. 21:99
private purchasers achieved only twelve to forty percent discounts. 86
Under the new drug benefit law, only private coverage providers, not
HHS, will be allowed to negotiate for discounts from the
manufacturers on behalf of Medicare recipients.87
Finally, the bill created a temporary prescription drug discount card
program, similar to the Bush administration drug discount card
proposal, to provide assistance until the full benefit's January 1, 2006,
implementation date.8  This provision made Medicare-endorsed
discount cards available as of June 2004.89 Beneficiaries have the
choice of at least two Medicare-endorsed cards but are only allowed to
purchase one card per beneficiary. 90 Card sponsors are required to
have three years experience in pharmacy benefit management9 and
are allowed to charge a maximum thirty-dollar enrollment fee to the
beneficiary purchasing the card. 92  Sponsors are also required to
provide "convenient access" to pharmacies (i.e., card sponsors cannot
require the beneficiary to use only mail-order pharmacies to obtain the
discounted prescription medicines).93
86. PUBLIC CITIZEN CONGRESS WATCH, MEDICARE PRIVATIZATION: BAD FOR
SENIORS AND PEOPLE WITH DISABILITIES 3 (2003), available at
http://www.citizen.org/ documents/PPO_.Final.pdf (last visited Nov. 28, 2004).
87. H.R. CONF. REP. No. 108-391, at 35, reprinted in 2003 U.S.C.C.A.N. at
2098.
88. Id. at Title 1, Subpart 4, reprinted in 2003 U.S.C.C.A.N. at 2131.
89. See U.S. HOUSE OF REPRESENTATIVES COMM. ON WAYS AND MEANS, supra
note 71, at 1; Robert D. Hershey, Jr., Discount Drug Cards are Coming: It's Time
to Do Your Homework, N.Y. TIMES, Apr. 13, 2004, at G4.
90. AM. PHARMACISTS ASS'N, MEDICARE DRUG BENEFIT COMPARED WITH
APHA KEY PRINCIPLES (July 28, 2004), available at
http://www.aphanet.org/govt/hs-comparison.pdf (last visited Nov. 28, 2004). See
also H.R. CONF. REP. No. 108-391, at 72, reprinted in 2003 U.S.C.C.A.N. at 2134.
91. Medicare Prescription Drug Discount Card and Transitional Assistance
Program, 42 C.F.R. § 403.806 (2004). See also AM. PHARMACISTS ASS'N, CENTERS
FOR MEDICARE AND MEDICAID SERVICES INTERIM FINAL RULE: MEDICARE
PROGRAM: MEDICARE PRESCRIPTION DRUG DISCOUNT CARD (2003), available at
http://www.aphanet.org/govt /discountdrugcard.htm (last visited Nov. 28, 2004).
92. H.R. CONF. REP. No. 108- 391, at 73, reprinted in 2003 U.S.C.C.A.N. at
2135.
93. Id. at 75-76, reprinted in 2003 U.S.C.C.A.N. at 2138.
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1I. RURAL SENIORS' NEED FOR A MEANINGFUL PHARMACY BENEFIT
A. Facing Greater Needs and Obstacles to Affordable Medicines
America's seniors have borne a significant burden from the recent
rise in pharmaceutical prices. While they make up only thirteen
percent of the nation's population, they account for more than one-
third of this country's total drug expenditures." Average prescription
drug spending per Medicare beneficiary rose from $1,610 in 2000 to
$2,322 in 2003. Out-of-pocket costs per beneficiary increased from
$644 to $999 during that same three-year period. Concurrently, nearly
four in ten Medicare beneficiaries in 2001 had incomes less than 160
percent of the federal poverty level;95 three in ten Medicare
beneficiaries were living on incomes under 135 percent of the poverty
level.96 In addition, because Medicare does not currently include
coverage for outpatient prescription costs, nearly four in ten
noninstitutionalized Medicare recipients have no prescription drug
coverage.9 These estimated fifteen million seniors who lack any drug
coverage spend an average of $350 a year more for prescription
medicines than the national average per Medicare beneficiary.
The remaining two-thirds of the Medicare population that have
supplemental insurance covering prescription drugs rely mainly on
coverage provided by former employers, Medicare+Choice, Medigap,
Medicaid, or other state pharmacy assistance programs. 99  About
94. AM. PUBLIC HEALTH ASS'N, MEDICARE PRESCRIPTION DRUG COVERAGE:
FACT SHEET (2003), available at http://www.apha.org/legislative/factsheets/
RxDrugs.pdf (last visited Nov. 28, 2004).
95. $13,744 for singles, $18,576 for couples. THE HENRY J. KAISER FAMILY
FOUND., STATE-LEVEL POVERTY DATA FOR THE MEDICARE POPULATION 1 (2003),
available at http://www.kff.org/medicare/6101-index.cfm (last visited Nov. 28,
2004). The federal poverty level in 2001 was $8,590 for an individual and $11,610
for a couple. U.S. DEP'T OF HEALTH AND HUMAN SERVS., supra note 70.
96. $11,597 for singles, $15,674 for couples. THE HENRY J. KAISER FAMILY
FOUND., supra note 95, at 1.
97. NAT'L Ass'N OF AREA AGENCIES ON AGING, MEDICARE PRESCRIPTION
DRUG BENEFIT 2003, at http://www.n4a.org/medicarerxdrugbenefit2003.cfm (last
visited Nov. 28, 2004).
98. See THE HENRY J. KAISER FAMILY FOUND., MEDICARE AND PRESCRIPTION
DRUG SPENDING CHARTPACK Figure 2 (2003), available at http://www.kff.org/
medicare/6087-index.cfm (last visited Nov. 28, 2004).
99. THE HENRY J. KAISER FAMILY FOUND., MEDICARE AND PRESCRIPTION
DRUGS: FACT SHEET (2003), available at http://www.kff.org/medicare/1583-06-
index.cfm (last visited Nov. 28, 2004).
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twenty-eight percent of all Medicare beneficiaries have prescription
drug coverage under plans sponsored by former employers. That
number, however, is shrinking; many employers who have not already
done so say they plan to eliminate or cut back on retiree health
benefits in the near future.'0 0 With the addition of a prescription drug
benefit to Medicare, more employers are expected to drop or reduce
their retiree prescription drug coverage.10 ' The new Medicare plan will
provide subsidies for employers who maintain prescription drug
coverage for their retirees.12 But, this is not necessarily an incentive
to maintain or increase current benefits. In fact, the statute may foster
reductions in retiree coverage because the employer can collect the
subsidy, even while cutting back retiree benefits, so long as its
coverage does not drop below the allowed minimum.
For those lacking employer-sponsored plans, another twenty-two
percent of Medicare beneficiaries have purchased individual plans
through Medicare+Choice 13 or Medigap.'04 However, the coverageprovided by these programs is often inadequate to meet the needs of
100. Id.
101. Robert Pear, Drug Law Is Seen as Leading to Cuts in Retiree Plans, N.Y.
TIMES, July 14, 2004, at Al. See also O'SULLIVAN, supra note 13, at 7-8.
102. H.R. CONF. REP. No. 108-391, at 62-63, reprinted in 2003 U.S.C.C.A.N. at
2125-26.
103. Medicare+Choice (M+C) was created under the Balanced Budget Act of
1997 to give beneficiaries additional options for selecting health plans, primarily
through HMOs. CTRS. FOR MEDICARE AND MEDICAID SERVS., supra note 15. See
also MARSHA GOLD & LORI ACHMAN, MATHEMATICA POLICY RESEARCH, INC.,
AVERAGE OUT-OF-POCKET HEALTH CARE COSTS FOR MEDICARE+CHOICE
ENROLLEES INCREASE 10 PERCENT IN 2003 at 7 n.1 (2003), available at
http://www.cmwf.org/publications/publicationsshow.htm?docid=221566
(last visited Nov. 28, 2004). Concerns have been raised in recent years about the
M+C program because M+C plans are not offered in some areas, and the program
has seen increased plan withdrawals and a decline in drug coverage. O'SULLIVAN,
supra note 13, at 5. Since 1999 drug coverage for M+C enrollees has dropped from
84% to 71%, and four in ten of those still covered are subject to a benefit cap of
$750 or less. THE HENRY J. KAISER FAMILY FOUND., supra note 99, at 1.
104. THE HENRY J. KAISER FAMILY FOUND., supra note 99, at 1. Medigap is
another type of insurance designed to supplement Medicare by providing coverage
for Medicare deductibles and coinsurance as well as some additional items and
services not included under Medicare. O'SULLIVAN, supra note 13, at 8. Only
three of the ten standard Medigap policies cover prescription drug costs, each to a
varying degree. Premiums for these plans also vary widely and have risen sharply
in recent years. THE HENRY J. KAISER FAMILY FOUND., supra note 99, at 1.
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an elderly beneficiary,05 especially if that person suffers from chronic
illness or multiple conditions requiring several medications. H1 Ten
percent of Medicare recipients qualify for prescription drug coverage
under Medicaid, and an additional two percent receive coverage under
other public initiatives such as state pharmacy assistance programs.07
For Medicare beneficiaries in rural areas, there are often further
obstacles to obtaining adequate prescription drug coverage. Seniors in
rural America tend to have more difficulty being able to afford the
medicines they need;1°1 over one-half of Medicare beneficiaries that
live in rural areas live below 200 percent of the federal poverty level.' 9
In 1999, one-half of all rural seniors had no prescription drug coverage
compared to only one-third of urban seniors.1 Only sixteen percent of
rural seniors had access to a Medicare+Choice plan in 2000, compared
to seventy-nine percent in urban areas."' Rural seniors are also less
likely to have health insurance from a former employer than their
urban counterparts' and less than one-half as likely to carry an
individually purchased plan that covers prescription drugs. "3
Adding to the difficulties for rural Medicare beneficiaries is the fact
that they often need more prescription medications than urban seniors.
Rural seniors, on average, develop more chronic health conditions and
in general tend to be in poorer health.'14 They are more likely to suffer
from a number of serious conditions, including hypertension, heart
disease, stroke, cancer, diabetes and emphysema. "' Because
105. CONG. RESEARCH SERV.,supra note 9, at 1.
106. See GOLD & ACHMAN, supra note 103, at 2.
107. THE HENRY J. KAISER FAMILY FOUND., supra note 99, at 1.
108. ANDREW F. COBURN & ERIKA ZILLER, RURAL POLICY RESEARCH INST.,
IMPROVING PRESCRIPTION DRUG COVERAGE FOR RURAL MEDICARE
BENEFICIARIES (2000), available at http://www.rupri.org/ruralHealth/publications/
(last visited Nov. 28, 2004).
109. Id.
110. Id.
111. Id.
112. Hearing on Medicare Cost-Sharing and Medigap Before the Subcomm. on
Health of the House Comm. on Ways and Means, 108th Cong. (2003) (statement of
Patricia Neuman, Sc.D., Vice President and Director, Medicare Policy Project,
Kaiser Medicare Policy Project, The Henry J. Kaiser Family Foundation),
available at http://waysandmeans.house.gov/hearings.asp?formmode=view&id= 3 38
(last visited Nov. 28, 2004).
113. COBURN & ZILLER, supra note 108.
114. Id.
115. Id.
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prescription medicines have become essential in the treatment of these
chronic conditions, rural elderly on average fill a higher number of
prescriptions each year than urban seniors.
1 6
More prescriptions and greater lack of adequate drug coverage
means rural seniors tend to pay more out-of-pocket for prescription
drugs, typically from more limited resources."' These seniors are thus
more likely to be faced with the desperate choice of buying groceries
or buying their medicines. Those faced with such a dilemma often fail
to follow the treatment regimens prescribed by their doctors," 8 seeking
to stretch their medicines as far as possible by skipping or reducing
doses. This ultimately puts them at risk for health complications that
could result in expensive doctor visits, hospital stays, or even nursing
home care. Given these risks, access to reasonably priced prescription
drugs and supportive pharmacy services is vital for seniors in rural
America.
B. Relying on Rural Community Pharmacies
In October 1999, Consumer Reports published a pharmacy
preference survey of 15,000 consumers."9  The survey found that
consumers preferred independently owned pharmacies over franchises,
supermarket drugstores, mass merchandisers, and corporate-run
chains.2 Reasons cited showed independent pharmacies as (1) more
professional, easier to talk to, and more sensitive to families' needs; (2)
providing more personal attention to customers; (3) providing more
useful information about prescription and nonprescription medicines;
and, (4) having prescriptions ready for pickup more often, having
shorter wait times for medicines, and getting out-of-stock medicine
faster.' The survey illustrates that consumers are often accustomed to
the services provided by their local community pharmacist.
Rural seniors rely on their pharmacist not only to get their
medicines, but also for other critical health care information and
122services. In many small communities where access to a physician orother health care provider is usually limited, the local pharmacist is
116. MAINE, supra note 6.
117. COBURN & ZILLER, supra note 108.
118. Id.
119. The ABCs of drugstores, CONSUMER REPORTS, Oct. 1999, at 39.
120. Id. at 43.
121. Id.
122. Epstein, supra note 7, at 8.
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sometimes the only health care provider in the community. 11 In rural
areas, pharmacists collectively outnumber primary care 
physicians. 124
Thus, where residents may have to wait several days to see the closest
doctor or dentist, they can often walk into the local drugstore that day
and get over-the-counter recommendations 2 5 or other medical
advice . 6  In fact, customers go to their pharmacists in hopes of
avoiding the doctor; some older customers even refer to the
pharmacist as "doctor.',
27
The ability to ensure that prescription medicines are not only taken,
but taken properly is essential for any elderly patient taking multiple
medications. In rural communities, because the pharmacist serves a
smaller customer base, he or she often knows customers on a personal
level, is likely to be more familiar with their medical history, and can• • 1 2 1
more easily monitor their adherence to prescribed therapies. Seniors121
in these areas are more likely to interact with their pharmacist,
allowing the pharmacist to perform critical medication therapy
management. 3 ° Moreover, due to the smaller number of physicians,
the pharmacist also knows the area doctors and can work closely with
them to develop care systems and manage their patients. 3' All of this
allows the pharmacist to effectively counsel the patient regarding
potentially harmful drug interactions as well as the consequences of
not adhering to his or her medicine regimen.
In addition to the pharmacist's trusted advice regarding
prescriptions, over-the-counter medicines, and when to see thed 132
doctor, many rural pharmacies offer other value-added services like
giving immunizations and delivering medicines to those who are
homebound. 133 For an elderly person trying to remain independent, a
123. Id. at 5.
124. Id. at 8. See also NAT'L RURAL HEALTH ASS'N, supra note 11, at 2.
125. See Rowley, supra note 8, at 2.
126. See Epstein, supra note 7, at 6.
127. Rowley, supra note 10, at 7.
128. See Epstein, supra note 7, at 8.
129. Paul L. Ranelli & Raymond T. Coward, Residential Differences in the Use
of Pharmacies by Older Adults and Their Communication Experiences, 12 J. OF
RURAL HEALTH 19 (1996) (abstract available at http://www.nrharural.org/search/
abs/16.html (last visited Nov. 28, 2004)).
130. See Epstein, supra note 7, at 8.
131. Id.
132. See id.
133. Rowley, supra note 8, at 2. See also RURAL POLICY RESEARCH INST. CTR.
FOR RURAL HEALTH POLICY & ANALYSIS, THE RURAL BENEFICIARY NEED FOR A
2004]
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pharmacy that delivers provides a critical service. Not only is it
possible for seniors to fill their prescriptions from home, they also
receive the benefit of social interaction with the deliverer. More
importantly, it provides an opportunity for a community member to
check on the well-being of that elderly individual.
Lastly, because the local pharmacist is the front line for health care
in a small community, he or she is often "on-call" twenty-four hours a
day, seven days a week. 35 Rural independent pharmacy owners will
provide their home phone number to customers in case of
emergencies, and regularly they come into the store during off hours,
sometimes in the middle of the night, to fill a prescription for a
customer when necessary.136
III. THE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND
MODERNIZATION ACT'S RELIANCE ON PRIVATE INSURERS LEAVES
RURAL COMMUNITY PHARMACIES AT RISK
In the effort to make prescription drugs more affordable for seniors,
legislators often overlook the importance of community pharmacies.
There are nearly 25,000 independent pharmacies in the United States,
which account for forty-four percent of all retail prescription drug sales
in the country. 37  However, as the number of pharmacy benefit
management companies and third-party buyers has increased,
community pharmacies are finding it increasingly difficult to stay in
MEDICARE DRUG BENEFIT DELIVERED THROUGH THE RURAL DELIVERY SYSTEM
10 (delivered to a Congressional Staff Briefing, Oct. 7, 2002), available at
http://www.rupri.org/ ruralHealth/presentations/muellerl00702.pdf (last visited
Nov. 28, 2004); COBURN & ZILLER, supra note 108, at 9; Rowley, supra note 10, at
5,7.
134. Incidental benefits of pharmacy delivery services can be analogized to the
benefits of in-home services provided by Area Agencies on Aging, such as "Meals-
on-Wheels" and "Friendly Visiting." See Area Agencies on Aging: A Link to
Services for Older Adults and their Caregivers, In-Home Services, at
www.n4a.org/aboutaaas.cfm (last visited Nov. 28, 2004).
135. Epstein, supra note 7, at 6.
136. Interview with U.S. Rep. Mike Ross (D-AR) in Washington, D.C. (Feb. 10,
2004). Congressman Ross and his wife own a small-town family pharmacy in
Prescott, Arkansas. Id. See also Epstein, supra note 7, at 6.
137. NAT'L COMMUNITY PHARMACISTS ASS'N, FACTS ABOUT AMERICA'S
PHARMACIST, at http://www.ncpanet.org/pharmacist/facts about-americas_
pharmacist.shtml (last visited Nov. 28, 2004).
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business. 138 Because both the new Medicare prescription drug benefit
and interim discount drug card program rely on PBMs to administer
the benefits, pressures that could lead to the demise of rural
pharmacies are likely to intensify.
A. The Emergence of Prescription Drug Discount Cards and Concerns
over Third-Party Purchasing
Prescription drug discount cards 3 1 originated as a means to lower the
cost of outpatient prescription medicines for those who lack adequate
prescription drug coverage.140  The cards are usually sponsored by
PBMs, insurance companies, retail stores, nonprofit organizations, or
state agencies.' 4' Typically, such cards are marketed directly to the
consumer through the use of direct mail, magazines, television, or the
Internet.142  Other cards may be offered through an employer,
association, or other group seeking to lower prescription costs for its
members. 43 The programs may charge a one-time enrollment fee,
though some charge annual or monthly fees. A few others are offered
for free. Once enrolled, the consumer receives a card that he or she
can use at participating pharmacies (and sometimes through mail
order) to obtain discounts on prescription medicines.'"
Prices available through the discount card are determined based on
several variables. Typically, the PBM or other third-party
sponsoring organization will negotiate rebates from the drug
manufacturers in return for promising increased utilization of their
drugs. 46 The sponsor satisfies this promise by having a "formulary" or
"preferred medication list" program, whereby the consumer may only
be able to obtain discounts on certain medications. 47 However, some
sponsors have disclosed that most of the discounts provided by the
138. See Epstein, supra note 7, at 1; Rowley, supra note 10, at 1; Rowley, supra
note 8, at 1.
139. Also sometimes referred to as "consumer cards," "point of sale cards," and
"100% copay" cards. THE HENRY J. KAISER FAMILY FOUND•, supra note 38, at 3.
140. Id.
141. Id. at 4.
142. Id.
143. Id. at 3.
144. Id.
145. Id. at 12.
146. COOK ET AL., supra note 9, at 14.
147. Id. at 13. A "formulary" is defined as a list "of preferred drugs within each
therapeutic class, usually combined with financial or other incentives to steer
patients toward the listed drugs (e.g., using different levels of copayment)." Id.
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cards come from reductions in the dispensing fees and mark-ups
normally charged by the pharmacy, rather than as a result of
manufacturers' rebates.' In fact, the rebates from manufacturers are
typically retained (in full or in part) by the PBM and not passed on to
consumers through lower prices.4 9
Discount savings vary among the different card programs because of
this and other factors: geography, manner of purchase (at a retail
pharmacy, online, or by mail), and type and quantity of the drug beingS 150
purchased. In addition, discounts for a particular medication may
vary from one purchase to the next based on normal price
fluctuations."' Prescription drug discount card sponsors claim to offer
discounts as high as sixty to seventy percent through their programs,"'
while CMS more conservatively estimates that the cards save seniors
ten to fifteen percent."' Critics charge, however, that the discounts are
"minimal savings at best.1 54 As evidence they point to a recent study
by the U.S. General Accounting Office (GAO) 55 that found savings
provided by several private discount drug cards in California, North
Dakota, and Washington, D.C., to be only three to five dollars on
148. THE HENRY J. KAISER FAMILY FOUND., supra note 38, at 12.
149. Id.
150. Id. at 3.
151. Id.
152. Id. at 6,13.
153. AM. PHARMACISTS ASS'N, supra note 91, at 8.
154. Press Release, Rep. Henry A. Waxman et al., New GAO Study Shows
That Prescription Drug Discount Cards Fail to Provide Meaningful Savings to
Seniors (Sep. 8, 2003), available at http://democrats.reform.house.gov/Documents/
20040628111641-06763.PDF (last visited Nov. 28, 2004). See also VILLARREAL,
supra note 38, at Summary.
155. U.S. GEN. ACCOUNTING OFFICE, REPORT TO CONG. REQUESTERS,
PRESCRIPTION DRUG DISCOUNT CARDS: SAVINGS DEPEND ON PHARMACY AND
TYPE OF CARD USED, GAO-03-0912 (2003) [hereinafter GAO REPORT]. GAO,
today known as the U.S. Government Accountability Office, is the non-partisan
"audit, evaluation, and investigative arm of Congress." Id. at 20. See also GAO
Human Capital Reform Act of 2004, Pub. L. 108-271, 118 Stat. 811 (2004)
(authorizing the name change and other modifications to GAO). In order to help
improve the efficiency and effectiveness of the federal government, GAO
"examines the use of public funds; evaluates federal programs and policies; and
provides analyses, recommendations, and other assistance to help Congress make
informed oversight, policy, and funding decisions." Id. at 20.
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average.' In addition, these savings are reduced by any one-time,
annual, or monthly fees required by the cards.'
5 7
Critics also have concerns over conflicts of interest that exist when
drug manufacturers own the PBM administering a discount drug card
program."" Many pharmacists see discount cards not just as marketing
tools for drug manufacturers, but also as unfair competition--such
programs force pharmacists to accept lower prices from consumers
while typically offering mail-order services that take away from the
pharmacists' business.'59 Additionally, a number of states have found
the marketing of discount card programs to be deceptive and have
enacted laws to prohibit "misleading, deceptive, or fraudulent"
advertising of these programs.' 6° As of October 2002, sixteen states
had laws regulating various aspects of discount card programs. 6 '
B. The Profit Squeeze from PBMs
As mentioned above, PBMs obtain most of the discounts/ • 162
beneficiaries receive through price concessions from pharmacists.
Though the PBMs characterize these concessions as "negotiated
discounts,' ' 63 the contracts offered to pharmacists by PBMs or other
third-party purchasers are usually on a "take-it-or-leave-it" basis. ' 64 In
return for providing discounted prices to consumers on
pharmaceuticals covered under a particular plan, the pharmacist
receives a reimbursement amount plus a dispensing fee from the third-
156. Waxman et al., supra note 154, at 2. See also VILLARREAL, supra note 38,
at Summary.
157. GAO REPORT, supra note 155, at 12.
158. COOK ET AL., supra note 9, at 35.
159. THE HENRY J. KAISER FAMILY FOUND., supra note 38, at 25.
160. GAO REPORT, supra note 155, at 4. See also THE HENRY J. KAISER
FAMILY FOUND., supra note 38, at 19.
161. GAO REPORT, supra note 155, at 4.
162. THE HENRY J. KAISER FAMILY FOUND., supra note 38, at viii, 12. See also
COOK ET AL., supra note 9, at 21.
163. See COOK ET AL., supra note 9, at 21, 47.
164. CONG. RESEARCH SERV., supra note 9, at 9. See also Integrating
Prescription Drugs into Medicare: Hearing Before the House Comm. on Ways and
Means, 107th Cong. (2002) (Statement of John M. Rector, Senior Vice President,
Government Affairs, and General Counsel, National Community Pharmacists
Association) [hereinafter Ways and Means Comm. Hearing], available at
http://waysandmeans.house.gov/hearings.asp?formmode=archive&hearing=25
(last visited Nov. 28, 2004); Rowley, supra note 10, at 3; Rowley, supra note 8, at 2.
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party buyer. In these contracts, however, pharmacists are forced to
accept lower reimbursements and dispensing fees. 66 Why is this
significant? It means that while pharmacists are still paying more to
purchase at wholesale the drugs they dispense, they are receiving less
from the customer and less reimbursement from the third-party buyer
to make up the discount.
Today, seventy-five percent of all prescriptions filled are paid for by
third parties. 67 As a result of the low reimbursement rates, most
pharmacies operate on profit margins as low as one to two percent.
168
For smaller rural pharmacies this poses significant difficulties because
they cannot offset the small margins through increased sales. 69
Decreased profit margins along with increased competition from chain
drugstores and mail-order pharmacies have already driven many small
pharmacies to close their doors.7  A Medicare drug benefit
administered by PBMs that promote the use of large chain pharmacy
networks or mail-order pharmacies could spell serious trouble for rural
pharmacies.71
In a statement to the House Small Business Committee, the general
counsel of the National Community Pharmacists Association offered
testimony from an independent pharmacist regarding the impact of
PBMs on her business. 172  Her store, she testified, delivered
medications to "an average of 35 residences and approximately 20
165. See THE HENRY J. KAISER FAMILY FOUND., supra note 38, at 12; COOK ET
AL., supra note 9, at 47.
166. See THE HENRY J. KAISER FAMILY FOUND., supra note 38, at 12; COOK ET
AL., supra note 9, at 21-22; Rowley, supra note 8, at 1-2.
167. Rowley, supra note 10, at 1 (citing information from the National
Association of Chain Drug Stores (NACDS)).
168. Id. at 3. See also Medicare Endorsed Prescription Drug Discount Cards
and Their Impact on Small Business: Hearing Before the House Comm. on Small
Business, 107th Cong. (2001) (Statement of John Rector, Senior Vice President,
Government Affairs, and General Counsel, National Community Pharmacists
Association) [hereinafter Small Business Comm. Hearing], available at
http://www.house.gov/smbiz /hearings/107th /2001/011025/rector.asp (last visited
Nov. 28, 2004).
169. Rowley, supra note 10, at 3.
170. For example, in Ohio, close to 300 independent pharmacies, many of them
in rural areas, closed their doors or sold-out to chains between 1992 and 1996.
Other states, such as Kansas, have seen similar results. See Epstein, supra note 7,
at 2-3.
171. Rowley, supra note 10, at 2.
172. Small Business Comm. Hearing, supra note 168.
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long-term care facilities daily., 173 Working with her husband "for a
combined average of 115 hours weekly," they were able to achieve "a
higher than average net profit in the neighborhood of 3%.,,174 She
concluded that "discounts of 15% or greater are unrealistic,
unattainable and [would be] financially devastating to community
pharmac[ies]. In fact, discounts of even 5% would have the same
disastrous effect.'
' 75
Stores like this, even if they can maintain enough profit to stay in
business, may not be able to do so without eliminating some relied
upon services such as delivery. To offer delivery, the pharmacy must
hire someone to run the deliveries or to watch the store while the
pharmacist takes the medicine to the customer. In addition, the
pharmacy must own or pay for the use of a delivery vehicle. For small• -• 176
pharmacies these costs are significant. Further, the increasing'77
shortage of pharmacists available in rural areas makes it difficult for
a pharmacy owner to find someone that can fill in while the regular
pharmacist--often the storeowner--is out. Many rural pharmacies
cannot afford to pay salaries that would attract extra help."' Clearly,
just a slight reduction in profits could jeopardize valuable services
offered by rural pharmacies.
In recent years members of the pharmacy profession and others have
voiced opposition to alleged abuses and conflicts of interest they
contend are prevalent in the PBM industry. 179 They argue that PBMs
shift consumers away from community pharmacies to highly profitable
mail-order companies owned by PBMs and promote under-utilization
of generic medicines by trying to switch patients to more expensive
173. Id.
174. Id.
175. Id.
176. Interview with U.S. Rep. Mike Ross, supra note 136.
177. See supra Introduction.
178. See Rowley, supra note 10, at 6.
179. See THE HENRY J. KAISER FAMILY FOUND., supra note 38, at 25; COOK ET
AL., supra note 9, at 35; Doug Smith, Shining light on the PBMs, ARK. TIMES, Aug.
19, 2004, at 9. According to the Arkansas Times, the Hot Spring County (Ark.)
Solid Waste Authority has filed a class action lawsuit against two large PBMs
(Caremark, Inc. and Medco Health Prescription Solutions) alleging that PBMs
"engage[] in deceptive practices for their own profit and drive up the cost of
prescription drugs in the process." Id. A third PBM listed in the article,
AdvancePCS, is a part of Caremark.
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drugs based on rebates received from drug manufacturers. 80 The
National Community Pharmacists Association claims that, according to
Wall Street analysts, PBMs make two to four times more profits on
mail-order drug sales than traditional pharmacy sales. The
Association contends that the PBMs' exclusive focus "on the
prescription drug product and [on] eliminating payment for traditional
professional community pharmacy services" has reduced patient access
to quality pharmacy care and increased significantly the failure of
patients to adhere to prescribed drug regimens. '82
Evidence appears to validate some of these contentions. In
September 2003, federal prosecutors filed a complaint seeking to
prevent such abuses by one PBM company, Medco Health Solutions,
Inc. 183  Allegations included that Medco cancelled and destroyed
prescriptions, failed to perform pharmacists' services required by law,
switched patients to different prescription medicines without their
knowledge, created false records of contact with physicians, solicited
and received inducements from drug manufacturers to favor their
products, and made false and misleading statements about its
conduct.'84 The complaint also stated that Medco's primary reason for
switching drugs was to increase revenues, that they ignored patient and
physician complaints about switches, and that they favored switching
even where other drugs were cheaper, more effective, or had less
expensive generic equivalents.18  According to the Department of
Justice, both patients and health care plans incurred increased costs
from follow-up doctor visits and tests due to these switches.186
180. Ways and Means Comm. Hearing, supra note 164, at 4. See also Smith,
supra note 179, at 9. The Hot Spring County Solid Waste Authority lawsuit
contends that PBMs keep the rebates they receive from drug companies for their
own profits and encourage the use of more expensive medicines. Id.
181. Ways and Means Comm. Hearing, supra note 164.
182. Id.
183. Complaint, United States v. Medco (E.D. Pa. filed Sept. 29, 2003) (No. 00-
CV-737).
184. Press Release, U.S. Dep't of Justice, U.S. Attorney, E.D. Pa., U.S. Files
Complaint in Intervention in Two "Whistleblower" Actions Against Medco
Health Solutions (Sept. 29, 2003).
185. Complaint at 45-47, Medco (No. 00-CV-737).
186. Press Release, U.S. Dep't of Justice, U.S. Attorney, E.D. Pa., The United
States Settles Its Anti-fraud Claims for Injunctive Relief and 20 State Attorneys
General Settle Unfair Trade Practices Claims Against Medco Health Solutions
(Apr. 26, 2004), available at http://www.usdoj.gov/usao/pae/News/Pr/2004/
apr/apr04.html (last visited Nov. 28, 2004).
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In April 2004, federal prosecutors in cooperation with twenty state
attorneys general reached an agreement with Medco settling the
federal claims for injunctive relief as well as state unfair trade practice
claims.' 8 Under the settlement, Medco agreed to pay $29 million in
damages, fees, and restitution to the states and patients. 88  The
agreement also requires Medco to make several disclosures to patients
when soliciting drug switches, and it prohibits Medco from soliciting
switches under certain circumstances.'89 The settlement, however, did
not dismiss federal damages claims against Medco.' 9 As of this
writing, the matter is still pending resolution; Medco denies the federal
allegations.' 9'
C. A Closer Look at the Provisions of the New Medicare Prescription
Drug Benefit
Under the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003, both the interim drug discount card
program and the permanent drug benefit (when implemented) will be
provided by private entities, likely PBMs such as Medco. '9 In fact,
discount card program sponsors are required to show "experience" in
pharmacy benefit management 93  as well as "expertise" in
administering such a program.' 94 It will be up to these PBMs to
187. Press Release, supra note 186.
188. Id. Specifically, Medco agreed to pay $20 million in damages and $6.6
million in fees and costs to the states, as well as $2.5 million to patients who
suffered expenses as a result of drug switches involving cholesterol medicines. Id.
189. Id. The circumstances where Medco may not solicit drug switches include
when (1) the proposed drug costs more than the prescribed drug, (2) no generic
equivalent to the proposed drug is offered where one is available for the
prescribed drug, and (3) more than one switch in two years in a therapeutic class is
made for any patient. Among the required disclosures by Medco are the
"minimum or actual cost savings for health plans," the difference in copayments,
financial incentives to Medco to make certain drug switches, and "material
differences in side effects between prescribed drugs and proposed drugs." Id.
190. Id.
191. Id.
192. H.R. CONF. REP. No. 108-391, at 36, 81, reprinted in 2003 U.S.C.C.A.N. at
2099, 2143. See also THE HENRY J. KAISER FAMILY FOUND., supra note 65, at 4.
193. AM. PHARMACISTS ASS'N, supra note 91, at 3.
194. H.R. CONF. REP. No. 108-391, at 81, reprinted in 2003 U.S.C.C.A.N. at
2143.
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determine the discounts and reimbursement rates that pharmacies will
receive under a particular Medicare drug plan.9
Undoubtedly, the goal for the Medicare prescription drug benefit
program is to lower drug costs. Given that these private carriers will
be for-profit entities in the business of insuring high-risk beneficiaries,
it is understandable that they will seek to keep pharmacy
reimbursements as low as possible. 96  For rural community
pharmacies, the increased use of prescription drugs likely to result
from the new Medicare benefit would mean a greater share of
prescriptions paid for by third parties and thinner profit margins. 9
This result assumes that the pharmacy will be included in a plan's
network of participating pharmacies. As evidenced by the shortage of
Medicare+Choice plans in rural areas, 98 the possibility of having only
one prescription drug benefit plan in a region is not unlikely. This
creates the possibility that some willing pharmacies may be excluded
from participation in a Medicare plan network. Even those that are
included could face competition from mail-order pharmacies.
Providers of the Medicare drug benefit plan must include in their
network "any willing pharmacy" meeting the provider's terms and
conditions.'9 Plans will be allowed to reduce copayments for
beneficiaries who purchase covered drugs from a participating
pharmacy.20 Providers will also be required to allow access to any
pharmacy outside of the plan's participating network.2 1' However, the
provider will be permitted to charge beneficiaries for the additional
cost of using a nonparticipating pharmacy by requiring a higher
coinsurance payment.2°
195. Id. at 75, 82, reprinted in 2003 U.S.C.C.A.N. at 2138, 2144.
196. See Rowley, supra note 10, at 3.
197. Id.
198. See HEALTH POLICY ALTERNATIVES, INC., MEDICARE PRESCRIPTION
DRUGS THROUGH PRIVATE DRUG-ONLY POLICIES: A DISCUSSION WITH
ACTUARIES 2 (2003), available at http://www.kff.org/medicare/6086-index.cfm (last
visited Nov. 28, 2004); Press Release, Public Citizen, Bush Medicare Plan Hurts
Seniors by Forcing Them Into HMOs and Private Insurance PPO Plans for Drug
Coverage (Feb. 13, 2003), available at http://www.citizen.org/pressroom/
print-release.cfm?ID=1334 (last visited Nov. 28, 2004).
199. H.R. CONF. REP. No. 108-391, at 20, reprinted in 2003 U.S.C.C.A.N. at
2083.
200. Id.
201. Id. at 20, reprinted in 2003 U.S.C.C.A.N. at 2084.
202. Id.
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Notably, the measure does require that a plan sponsor's network
must include "a sufficient number of pharmacies that dispense (other
than by mail order) drugs directly to patients to ensure convenient
access . ,201 With the combination of this provision and the "any
willing pharmacy" stipulation, some rural pharmacies that might not
otherwise be included will likely be able to participate in a plan's
pharmacy network. This may save nearby seniors from paying more or
looking elsewhere to buy their prescriptions. There are no guarantees,
however, that community pharmacies will be able to meet whatever
terms and conditions the plan provider requires, or that plans will not
charge reduced prices for mail-order purchases to entice beneficiaries
to use mail order over traditional pharmacies. Moreover, the current
rule set forth by the Medicare Administrator regarding pharmacy
network access only requires that seventy percent of beneficiaries be
within fifteen miles of a participating pharmacy.z° This could leave
close to one-third of rural seniors without "convenient access" to a
participating pharmacy. For this group, an increased coinsurance
payment for using an outside pharmacy could effectively prevent
beneficiaries from using their local pharmacy.
A number of other provisions included in the Medicare drug
coverage plan could be beneficial to ensuring access to rural pharmacy
services. One such provision gives traditional pharmacies permission
to dispense ninety-day supplies of medications, as mail-order
pharmacies are currently allowed. This should help level the playing
field for community pharmacies.0 5 The measure also requires plans to
include medication therapy management, as discussed above, to be
developed in collaboration with practicing doctors and pharmacists.
Under this provision benefit providers are required to "take into
account" the costs associated with medication therapy management
when determining reimbursement amounts to pharmacists.20 6 This
does not ensure, however, that pharmacists will be adequately
reimbursed for these services. Because rural pharmacies often tend to
provide more extensive monitoring and counseling services, chances
are greater that the reimbursement rates will not accurately reflect the
value of the services performed.
With the increased use of prescription drugs comes a likelihood of
adverse drug interactions, a serious risk for rural seniors who
203. Id. at 20, reprinted in 2003 U.S.C.C.A.N. at 2083.
204. AM. PHARMACISTs Ass'N, supra note 91, at 4.
205. H.R. CONF. REP. No. 108-391, at 20, reprinted in 2003 U.S.C.C.A.N. at
2084.
206. Id. at 22-23, reprinted in 2003 U.S.C.C.A.N. at 2086, 2087.
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otherwise have less access to medical information via the Internet or
other resources. Thus, the role of the pharmacist in providing
pharmaceutical therapy management can be critical. Notwithstanding
the beneficial provisions discussed above, the current Medicare drug
plan provides neither guarantees that rural pharmacies in isolated
communities will be included nor financial incentives to help small
pharmacies qualify for participation. Even for those that are included,
the law as enacted provides little help for community pharmacies to
prevent the increasing financial strain. For many of these pharmacies,
the increased business from seniors utilizing their new Medicare
prescription drug benefit is unlikely to improve profits as much as the
decreased reimbursements are likely to stretch them until the
pharmacy can no longer maintain important value-added services such
as delivery and immunizations, or simply no longer survive.
IV. IMPACT OF LOSING RURAL DRUGSTORES: WHAT CAN BE DONE
TO PREVENT THE ELIMINATION OF THE RURAL PHARMACY?
A. Costs to Beneficiaries
When a rural pharmacy closes, local seniors may be faced with
having to drive thirty, fifty, or even one hundred miles to the nearestd. 207
drugstore. For these and other seniors, mail order appears to be an
easy and reliable option. The use of mail-order pharmacies, however,
involves several drawbacks not found with traditional pharmacies.
Mail-order pharmacies typically dispense a medicine in a ninety-day
supply, the cost of which can be significantly higher than the normal• 208
thirty-day supply. In addition, mail order takes time. In the fall 2002
Rural Health News, a small-town pharmacist and former hospital
administrator testified that customers would come into his store and
ask to be loaned a few pills until their mail order arrived.2°9 More
importantly, a postal carrier cannot advise a senior on how to take
medicines properly, potential drug interactions, or when to see the
doctor; a postal carrier will not know the senior's medical status and
cannot monitor whether that senior is following his or her prescribed
210drug regimen. When a rural pharmacy closes, seniors in that areahave lost not only potential access to medicine, but also a critical
207. NAT'L RURAL HEALTH ASS'N, supra note 11, at 3.
208. GAO REPORT, supra note 155, at 12.
209. Rowley, supra note, 10 at 5.
210. See NAT'L RURAL HEALTH ASS'N, supra note 11, at 3.
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source for medication management and other health care services--the
personal interaction with their pharmacist.
When seniors cannot get to another pharmacy or do not know how
to use mail order, they may be forced to go without their medicines.
Even when they find alternative sources from which to purchase
prescriptions, there is increased likelihood that they may not take
those prescriptions appropriately. As noted earlier, according to
congressional testimony by the National Community Pharmacists
Association, the PBMs' focus on providing prescription drugs but not
pharmacist services has caused "a significant increase in non-
compliance with the drug regimen prescribed by physicians. 2 . When
the elderly cannot get the medicines they need or when they fail to
take them as prescribed, complications can include doctor visits,
hospitalization, and potential long-term care costs. An elderly person
that ends up in a hospital or long-term care facility may never return
home, and medical bills can quickly erode a senior's life savings.
Prescription drugs help seniors avoid these outcomes to live longer,
more independent lives, but only when seniors have access to
affordable medicines and the guidance to use them properly.
B. Costs to Our Health Care System and Our Rural Communities
Unnecessary doctor visits, hospitalizations, and nursing home stays
not only deprive seniors of their livelihood, but also place a significant
burden on America's health care system. Adverse medication events
cost our nation's health care system roughly $177 billion 212 and our
211
economy an estimated twenty million workdays annually. With the
use of pharmaceuticals surely to rise as a result of the new Medicare
drug benefit, one can expect adverse medication events to increase as
well.
When a rural pharmacy closes, the costs to the health care system as
a whole add up quickly. What would have been a $100 prescription
expense may increase exponentially due to additional physician,
hospital, or nursing home expenses. While the private Medicare
insurance carriers will pay most of the prescription costs, the taxpayers
will likely pick up a much higher tab for doctor visits and hospital stays
through Medicare Parts A and B. If the beneficiary ends up in a
nursing home and qualifies for Medicaid, which often is the case in
211. Small Business Comm. Hearing, supra note 168.
212. F. R. Ernst & A. J. Grizzle, Drug-Related Morbidity and Mortality:
Updating the Cost-of-Illness Model, 41 J. AM. PHARMACEUTICAL Ass'N. 192-199
(2001).
213. Small Business Comm. Hearing, supra note 168.
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rural areas, again the taxpayers, via both the state and federal
governments, will have to pay costs that the senior cannot. As many
states have been forced to cut funding for Medicaid programs in recent
years to balance their budgets, any additional costs or even lost savings
could be difficult for those states to absorb. These many thousands of
dollars can be saved simply by ensuring that seniors know how to take
their medicines properly.
To see how devastating the loss of rural pharmacies could be to the
communities they serve one need only look at the impact that changes
in 1983 to Medicare's hospital payment system had on rural health care
214facilities. As a result of these changes, 438 rural hospitals over a
fifteen-year period were driven out of business.215 Rural clinics and
hospitals provide not only critical medical services for small
communities and their surrounding areas, but also good paying jobs
that help support struggling rural economies. These closures left many
small communities reeling from the loss of jobs from their local
economy and cost even more rural Americans access to vital hospice
216
care services.
Twenty-one percent of all Medicare beneficiaries live in rural
211regions of the country, whereas only fifteen percent of pharmacies
and only twelve percent of pharmacists are located in such areas.1
Those numbers are shrinking as more rural pharmacies are shutting
their doors and older pharmacists are retiring with no one to take their
places. 9 When these entities close, it not only leaves the community
with a health care void, but also strips from the area jobs, economic
revenues, and community involvement. Small town pharmacists are
often among the most educated and active civic leaders in their
communities.2 0 Rural experts estimate that every job at a small-town
pharmacy creates 1.2 to 1.6 more jobs and generates $1.20 to $1.60
more for the local economy for every dollar paid in salaries at the
214. NAT'L RURAL HEALTH ASS'N, supra note 11, at 1.
215. Id.
216. See id. This provides a partial explanation of why, in some areas, the
pharmacist is the only health care provider left.
217. Carol Ukens, Will Medicare Rx Benefit Threaten Rural Pharmacy? 147
DRUG Topics 29 (June 16, 2003), available at http://www.drugtopics. corn/
drugtopics /issue/issueDetail.jsp?id=3838 (last visited Nov. 28, 2004).
218. NAT'L RURAL HEALTH Ass'N, supra note 11, at 2.
219. See Rowley, supra note 10, at 7.
220 Id
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pharmacy.22 1 These communities and the seniors that live nearby
simply cannot afford to lose more health care providers.
C. Steps to Prevent the Loss of Rural Pharmacies
Medicare was created to provide our nation's elderly with adequate,
affordable health care. Adding coverage for prescription drugs under
Medicare should give seniors the ability to obtain and utilize the
medicines they need to get well or stay healthy. The full benefits of
this coverage, however, will not be realized if care is not taken to
prevent the loss of pharmacies on which seniors often rely. The closing
of many rural hospitals over the last two decades has shown that
poorly structured Medicare payments can deal a severe blow to the
rural health care systems. The Medicare prescription drug benefit
legislation, as passed, appears likely to produce similar effects on
another one of those critical rural health care providers: the
community pharmacy.
To ameliorate such effects a number of changes to the new Medicare
drug program should be considered. First, Congress should give the
program the ability to use the collective purchasing power of its forty
million beneficiaries to negotiate price concessions from
pharmaceutical manufacturers. If the goal of the prescription drug
benefit is to make prescription medicines more affordable and
accessible for seniors, the most logical way to do so is to address high
drug prices at the source the drug manufacturers. Dividing the
purchase power of our seniors into many groups as the new program
will do if it takes effect as currently written diminishes the negotiating
muscle of the providers and ultimately reduces the amount of savings
that could be realized. Squeezing price concessions out of pharmacies
does not provide meaningful savings to seniors. Moreover, it harms
many vital pharmacies already struggling to make a profit.
Proponents of the current plan argue that allowing the federal
government to negotiate price concessions on behalf of its Medicare
beneficiaries would constitute price-fixing.222 Regardless of the label,
many countries, including Canada and several European nations,
engage in such practices, thereby allowing seniors in those countries to
223
benefit from significantly lower drug prices. Pharmaceutical
221. Id. See also NAT'L RURAL HEALTH ASS'N, supra note 11, at 3.
222. Fischer, supra note 84. See also CONG. RESEARCH SERV., supra note 9, at
16.
223. ALAN SAGER & DEBORAH SOCOLAR, LOWER U.S. PRESCRIPTION DRUG
PRICES ARE VITAL TO BOTH PATIENTS AND DRUG MAKERS 2 (2003), available at
http://dcc2.bumc.bu.edu/hs/ushealthreform.htm (last visited Nov. 28, 2004).
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manufacturers argue that such price-fixing would greatly restrict their
ability to produce new life-saving medicines. 24 In 2000, however, the
top ten drug manufacturers, while collectively achieving the highest
225profits of any industry, spent more than twice as much on advertising
26tand administrative costs as on research and development.
The Department of Veterans' Affairs has already shown the benefits
of federal government negotiations with drug manufacturers through
the large savings achieved through wholesale purchases of prescription
227medicines. Allowing the Medicare program to negotiate price
discounts on behalf of all Medicare beneficiaries would bring more
meaningful savings to our seniors. Moreover, it could help eliminate
concerns of collusion between drug manufacturers and PBMs that may
be affiliates of the manufacturers. More importantly, it will reduce the
profit squeeze on small pharmacies by eliminating the need for
Medicare drug benefit providers to force them to accept price
concessions. Legislation has already been introduced to amend the
current law by allowing the federal government to use its collective
228bargaining power. Congress should take the initiative to enact such a
measure.
A second option that should be considered would be to allow
pharmacists to negotiate collectively with Medicare benefit providers.
Again, although PBMs characterize price concessions from pharmacies
as "negotiated," pharmacists are in reality forced to accept whatever
224. CONG. RESEARCH SERV., supra note 9, at 16. See also, e.g.,
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/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=13796 (last visited
Nov. 28, 2004).
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reimbursement third-party purchasers offer, "take-it-or-leave-it.
229
Further, it is forbidden under antitrust laws for independently owned
230
pharmacies to join together to contract with third-party purchasers.
In the 106th Congress, the House passed bipartisan legislation to
allow such negotiations, but the measure was not enacted."' This
legislation would have allowed health care professionals to collectively
bargain with health care plans regarding services contracts.
232
However, this measure and similar bills subsequently introduced
233
would have excluded any negotiations pertaining to benefits provided
under Medicare, Medicaid, and other government health insurance
programs. 3 Such legislation, provided that it did not except
negotiations relating to the new Medicare benefit, would allow
pharmacies to demand that discounts be passed through directly from
the drug manufacturer to the consumer rather than at the expense of
pharmacies by providing pharmacists the ability to collectively
negotiate with health insurance providers. This negotiating authority
would protect the viability of the rural pharmacies, allowing them to
provide valuable services that rural seniors need. Congress should
continue to consider such modifications.
Lastly, the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 should be amended to ensure appropriate
payments to pharmacists for the medication management services they
provide. Commendably, the Act specifies that providing plans must
take this into account when determining reimbursement fees to be paid
to pharmacies.2  Although the Act offers general guidelines for
medication therapy management programs,236 it is ultimately up to each
plan to determine what an appropriate program is and what
229. CONG. RESEARCH SERV., supra note 9, at 9. See also Small Business
Comm. Hearing, supra note 168; Rowley, supra note 10, at 3; Rowley, supra note 8,
at 2.
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(2000).
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235. H.R. CONF. REP. No. 108-391, at 23, reprinted in 2003 U.S.C.C.A.N. at
2087.
236. Id. at 22-23, reprinted in 2003 U.S.C.C.A.N. at 2086.
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appropriate fees are.z7 There are no guarantees that the fees decided
upon by an individual plan will adequately compensate the
pharmacists for the services they provide. Rural pharmacies, which
generally offer more personal interaction and more extensive patient
counseling, will likely be reimbursed at the same rate as other
pharmacies that offer fewer services.
Congress should consider amending the medication therapy
management provision to specifically mandate that rural pharmacists
be consulted by providers when making their pharmacy
reimbursement determinations. Such a measure, for example, could
require that fees be determined in consultation with licensed and
practicing pharmacists from different regions, with at least one of them
being from a rural pharmacy. This requirement would provide
assurance of a voice for rural pharmacies in each plan's decision
making process, helping to insure seniors from losing the valuable
pharmacy services that are critical to quality health care in rural
America.
CONCLUSION
Making prescription drug coverage a part of Medicare is crucial to
bringing this critical government health insurance program up to speed
with today's medical care. All seniors deserve access to affordable
health care that includes prescription medicines. To ensure quality
care for our seniors, especially those in rural areas, a Medicare
prescription drug benefit must protect access to all the vital services
provided by their local pharmacist. The Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 fails to adequately
safeguard rural pharmacies. Its reliance on private entities, namely
PBMs, leaves these pharmacies in jeopardy of eliminating needed
services, like delivery, or simply closing their doors for good. Unless
Congress acts to alleviate some of the strains on rural pharmacies, our
nation's rural health care system, our small towns and communities,
and especially our rural seniors may pay a high price.
237. See id. at 23, reprinted in 2003 U.S.C.C.A.N. at 2087.
